Edwards Lifesciences: $20 Billion TAM And A Meaningful Opportunity To Compound (NYSE:EW)

seekingalpha.com · 2026-09-07

Baron Asset Fund initiated a position in Edwards Lifesciences due to its dominant heart valve market share. Read the full analysis for more details.